Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial.

Pinder SE, Duggan C, Ellis IO, Cuzick J, Forbes JF, Bishop H, Fentiman IS, George WD; UK Coordinating Committee on Cancer Research (UKCCCR) Ductal Carcinoma In Situ (DCIS) Working Party.

Br J Cancer. 2010 Jun 29;103(1):94-100. doi: 10.1038/sj.bjc.6605718. Epub 2010 Jun 1.

2.

Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.

Boyages J, Delaney G, Taylor R.

Cancer. 1999 Feb 1;85(3):616-28.

PMID:
10091735
3.

259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.

Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, Leone A, Gazzotti F, Gagliardi S, De Cataldis A, Taffurelli M.

Breast Cancer Res Treat. 2008 Jun;109(3):405-16. Epub 2007 Aug 9. Review.

PMID:
17687650
5.
6.

Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy.

Kestin LL, Goldstein NS, Lacerna MD, Balasubramaniam M, Martinez AA, Rebner M, Pettinga J, Frazier RC, Vicini FA.

Cancer. 2000 Feb 1;88(3):596-607.

PMID:
10649253
7.

Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery.

Boland GP, Chan KC, Knox WF, Roberts SA, Bundred NJ.

Br J Surg. 2003 Apr;90(4):426-32.

PMID:
12673743
8.
9.

Is there a low-grade precursor pathway in breast cancer?

King TA, Sakr RA, Muhsen S, Andrade VP, Giri D, Van Zee KJ, Morrow M.

Ann Surg Oncol. 2012 Apr;19(4):1115-21. doi: 10.1245/s10434-011-2053-0. Epub 2011 Sep 21.

PMID:
21935747
10.

Ductal carcinoma in situ of the breast (DCIS) with heterogeneity of nuclear grade: prognostic effects of quantitative nuclear assessment.

Chapman JA, Miller NA, Lickley HL, Qian J, Christens-Barry WA, Fu Y, Yuan Y, Axelrod DE.

BMC Cancer. 2007 Sep 10;7:174.

11.

Histological markers that predict clinical recurrence in ductal carcinoma in situ of the breast: an Australian population-based study.

Provenzano E, Hopper JL, Giles GG, Marr G, Venter DJ, Armes JE.

Pathology. 2004 Jun;36(3):221-9.

PMID:
15203725
12.

Cytologic diagnosis and grading of ductal carcinoma in situ.

McKee GT, Tildsley G, Hammond S.

Cancer. 1999 Aug 25;87(4):203-9.

PMID:
10455208
13.
14.
15.

A proposal for the histopathological diagnosis of ductal carcinoma in situ of the breast.

Moriya T, Kasami M, Akiyama F, Ichihara S, Kurosumi M, Tsuda H, Umemura S, Akashi-Tanaka S, Imamura H, Iwase H, Shin E, Harada Y, Mitsuyama S, Ohuchi N.

Breast Cancer. 2000;7(4):321-5.

PMID:
11114858
16.

Prognostic classification of breast ductal carcinoma-in-situ.

Silverstein MJ, Poller DN, Waisman JR, Colburn WJ, Barth A, Gierson ED, Lewinsky B, Gamagami P, Slamon DJ.

Lancet. 1995 May 6;345(8958):1154-7.

PMID:
7723550
17.

Outcome and prognostic factors for local recurrence in mammographically detected ductal carcinoma in situ of the breast treated with conservative surgery and radiation therapy.

White J, Levine A, Gustafson G, Wimbish K, Ingold J, Pettinga J, Matter R, Martinez A, Vicini F.

Int J Radiat Oncol Biol Phys. 1995 Feb 15;31(4):791-7.

PMID:
7860390
18.

Ductal carcinoma in situ of the breast: reproducibility of histological subtype analysis.

Scott MA, Lagios MD, Axelsson K, Rogers LW, Anderson TJ, Page DL.

Hum Pathol. 1997 Aug;28(8):967-73.

PMID:
9269834
19.

An attempt to independently verify the utility of the Van Nuys Prognostic Index for ductal carcinoma in situ.

MacAusland SG, Hepel JT, Chong FK, Galper SL, Gass JS, Ruthazer R, Wazer DE.

Cancer. 2007 Dec 15;110(12):2648-53.

Items per page

Supplemental Content

Write to the Help Desk